163 related articles for article (PubMed ID: 33660585)
1. Dexamethasone suppression test versus selective ovarian and adrenal vein catheterization in identifying virilizing tumors in postmenopausal hyperandrogenism - a systematic review and meta-analysis.
Tng EL; Tan JM
Gynecol Endocrinol; 2021 Jul; 37(7):600-608. PubMed ID: 33660585
[TBL] [Abstract][Full Text] [Related]
2. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
Kaltsas GA; Mukherjee JJ; Kola B; Isidori AM; Hanson JA; Dacie JE; Reznek R; Monson JP; Grossman AB
Clin Endocrinol (Oxf); 2003 Jul; 59(1):34-43. PubMed ID: 12807501
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin-Releasing Hormone Analogue Stimulation Test Versus Venous Sampling in Postmenopausal Hyperandrogenism.
Tng EL; Tan JMM
J Endocr Soc; 2021 Jan; 5(1):bvaa172. PubMed ID: 33324863
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
Stanczyk FZ; Saxena T; Lobo RA
J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067
[TBL] [Abstract][Full Text] [Related]
5. Selective venous catheterization in the evaluation of hyperandrogenism.
Bricaire C; Raynaud A; Benotmane A; Clair F; Paniel B; Mowszowicz I; Wright F; Moreau JF; Kuttenn F; Mauvais-Jarvis P
J Endocrinol Invest; 1991 Dec; 14(11):949-56. PubMed ID: 1806613
[TBL] [Abstract][Full Text] [Related]
6. The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women.
Kaltsas GA; Isidori AM; Kola BP; Skelly RH; Chew SL; Jenkins PJ; Monson JP; Grossman AB; Besser GM
J Clin Endocrinol Metab; 2003 Jun; 88(6):2634-43. PubMed ID: 12788867
[TBL] [Abstract][Full Text] [Related]
7. Hyperandrogenism of ovarian etiology: utilizing differential venous sampling for diagnosis.
Bailey AP; Schutt AK; Carey RM; Angle JF; Modesitt SC
Obstet Gynecol; 2012 Aug; 120(2 Pt 2):476-479. PubMed ID: 22825271
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS.
Chen F; Chen M; Zhang W; Yin H; Chen G; Huang Q; Yang X; Chen L; Lin C; Yin G
J Ovarian Res; 2021 Feb; 14(1):32. PubMed ID: 33583431
[TBL] [Abstract][Full Text] [Related]
9. Postmenopausal hyperandrogenism.
Yoldemir T
Climacteric; 2022 Apr; 25(2):109-117. PubMed ID: 33988479
[TBL] [Abstract][Full Text] [Related]
10. [The ovarian origin of hiperandrogenism in the postmenopausal woman the adrenal adenoma--a case report].
Mrozińska S; Kiałka M; Doroszewska K; Milewicz T; Jach R
Przegl Lek; 2015; 72(7):387-90. PubMed ID: 26817354
[TBL] [Abstract][Full Text] [Related]
11. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women.
Barnes RB; Rosenfield RL; Ehrmann DA; Cara JF; Cuttler L; Levitsky LL; Rosenthal IM
J Clin Endocrinol Metab; 1994 Nov; 79(5):1328-33. PubMed ID: 7962325
[TBL] [Abstract][Full Text] [Related]
12. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
[TBL] [Abstract][Full Text] [Related]
13. Value of selective venous catheterization in the diagnosis of hyperandrogenism.
Hickman LC; Goodman L; Falcone T
Fertil Steril; 2017 Dec; 108(6):1085. PubMed ID: 29100622
[TBL] [Abstract][Full Text] [Related]
14. Adrenal- and ovarian-vein steroids and LH response to GnRH in two patients with virilizing adrenocortical adenoma studied by selective catheterizations.
Ruutiainen K; Satokari K; Anttila L; Erkkola R
Horm Res; 1992; 37(1-2):49-53. PubMed ID: 1398477
[TBL] [Abstract][Full Text] [Related]
15. Coincidental diagnosis of an occult hilar steroid cell tumor of the ovary and a cortisol-secreting adrenal adenoma in a 49-year-old woman with severe hyperandrogenism.
Gorgojo JJ; Almodóvar F; López E; Vicente del Cerro J; Tejerina E; Donnay S
Fertil Steril; 2003 Dec; 80(6):1504-7. PubMed ID: 14667891
[TBL] [Abstract][Full Text] [Related]
16. Preoperative localization of virilizing tumors by selective venous sampling.
Weiland AJ; Bookstein JJ; Cleary RE; Judd HL
Am J Obstet Gynecol; 1978 Aug; 131(7):797-802. PubMed ID: 686072
[TBL] [Abstract][Full Text] [Related]
17. Hyperandrogenism. Tests that simplify evaluation.
Hammond MG; Talbert LM; Groff TR
Postgrad Med; 1986 Feb; 79(3):107-13. PubMed ID: 3003722
[No Abstract] [Full Text] [Related]
18. [Virilizing ovarian tumours. Contribution of selective venous catheterization to the diagnosis].
Giacomini P; Vincens M; Moreau JF; Paniel B; Pelissier C; Kuttenn F; Mauvais-Jarvis P
Nouv Presse Med; 1982 Oct; 11(43):3189-93. PubMed ID: 7177836
[TBL] [Abstract][Full Text] [Related]
19. Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.
Hirschberg AL
J Clin Endocrinol Metab; 2023 Apr; 108(5):1243-1253. PubMed ID: 36409990
[TBL] [Abstract][Full Text] [Related]
20. Hyperandrogenism in a postmenopausal woman: diagnostic and therapeutic challenges.
Cheng V; Doshi KB; Falcone T; Faiman C
Endocr Pract; 2011; 17(2):e21-5. PubMed ID: 21247854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
